Sort
46,585 grants matching “heart failure”
Novel Lipid 2nd Messengers Regulating Bioenergetics and Signaling in Human Myocardium
$569,592Richard W Gross · Washington University · R01 · FY2024 · HL
Role of Kir4.1 in Regulating NCC and ROMK in DCT
$569,579Wen-Hui Wang · New York Medical College · R01 · FY2019 · DK
Role of Kir4.1 in Regulating NCC and ROMK in DCT
$569,579Wen-Hui Wang · New York Medical College · R01 · FY2020 · DK
Role of Kir4.1 in Regulating NCC and ROMK in DCT
$569,579Wen-Hui Wang · New York Medical College · R01 · FY2017 · DK
Proteomics of Cardiometabolic and Renal Traits in African Americans
$569,531Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
Chicago Healthy Aging Low Risk MRI Angiography (CHARISMA) Study
$569,501Donald M Lloyd-Jones · Northwestern University At Chicago · R01 · FY2009 · HL
Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension
$569,497Zhiyu Dai · Washington University · R01 · FY2025 · HL
Altered Creatine Kinase Energy Metabolism in Human Heart Failure
$569,497Robert G Weiss · Johns Hopkins University · R01 · FY2012 · HL
Altered Creatine Kinase Energy Metabolism in Human Heart Failure
$569,497Robert G Weiss · Johns Hopkins University · R01 · FY2011 · HL
Partners Heart Failure Network
$569,493Lynne W. Stevenson · Brigham And Women'S Hospital · U01 · FY2008 · HL
L-type calcium channel trafficking and modulation in heart
$569,463Henry M Colecraft · Columbia University Health Sciences · R01 · FY2015 · HL
Insulin Stimulation of Hepatic Fatty Acid Synthesis via SREBP-1 c
$569,461Michael S Brown · Ut Southwestern Medical Center · P01 · FY2015 · HL
Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure
$569,442Yu-Long Li · University Of Nebraska Medical Center · R01 · FY2024 · HL
Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis
$569,270Peter Ganz · University Of California, San Francisco · R01 · FY2022 · HL
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
$569,269Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · NS
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
$569,269Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · NS
A dialogue between neutrophils and monocytes for effective resolution of inflammation following acute myocardial injury
$569,242Prabhakara Reddy Nagareddy · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · HL
Transition of Care in CKD (TC-CKD)
$569,175Kamyar Kalantar-Zadeh · University Of California-Irvine · U01 · FY2015 · DK
Biomechanics of early mammalian cardiogenesis
$569,168Irina Larina · Baylor College Of Medicine · R01 · FY2018 · HD
Cell biology of vasopressin-induced water channels
$569,145Dennis Brown · Massachusetts General Hospital · R01 · FY2013 · DK
Multiscale Model of Neural Control of Breathing
$569,099Ilya A Rybak · Drexel University · R01 · FY2012 · NS
Pediatric Cardiomyopathy Specimen Repository
$569,096Jeffrey A Towbin · Baylor College Of Medicine · R01 · FY2007 · HL
Effect of Statin Therapy on Disease Progression in Children with ADPKD
$569,019Robert W Schrier · University Of Colorado Denver · R01 · FY2009 · DK
Progressive seizure-induced cardiorespiratory dysfunction in a novel mutant rat model of seizure disorder
$568,989Matthew Robert Hodges · Medical College Of Wisconsin · R01 · FY2024 · HL
Heart Failure Disparities in Native Hawaiians
$568,909Todd B Seto · Queen'S Medical Center · U01 · FY2007 · HL